Depatuxizumab MMAE

Depatuxizumab MMAE is an antibody-drug conjugate (ADC) comprising an anti EGFR monoclonal antibody (Depatuxizumab) and the cytotoxic agent Monomethyl auristatin E (MMAE). Depatuxizumab inhibits the growth of xenograft models of mutant EGFRvIII and wild-type EGFR. Depatuxizumab MMAE has a Drug-to-antibody ratio (DAR) of 4.0, its molecular weight is 148kDa. This product is for research use only.

Product Details
Species Reactivity	Human
Type	Antibody-drug conjugate
ADC antibody	Depatuxizumab (anti-EGFR)
ADC cytotoxin (drug)	MMAE
Immunogen	Human EGFR
DAR (Drug to Antibody Ratio)	~ 4.0
Purity	N/A
Molecular Weight	148kDa
Storage Condition	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Storage Buffer	1xPBS